Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The application of functional genomics to Alzheimer's disease.

Pharmacogenomics - 1 Sept 2003

Cacabelos Ramón

Abstract excerpt

Alzheimer's disease (AD) is a polygenic/complex disorder in which more than 50 genetic loci are involved. Primary and secondary loci are potentially responsible for the phenotypic expression of the disease under the influence of both environmental factors and epigenetic phenomena. The construction of haplotypes as genomic clusters integrating the different genotype combinations of AD-related genes is a suitable...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Amyloid beta-Peptides
Share to Apolipoproteins E

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2D6

Share to Genomics

Share to Pharmacogenetics

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 12943467
DOI: 10.1517/phgs.4.5.597.23795

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The application of functional genomics to Alzheimer's disease.PMID 12943467Read ↗

Pharmacogenomics in Alzheimer's disease.Semantic proximity Read ↗

Influence of pharmacogenetic factors on Alzheimer's disease therapeutics.Semantic proximity Read ↗

Genomic characterization of Alzheimer's disease and genotype-related phenotypic analysis of biological markers in dementia.Semantic proximity Read ↗

Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.Semantic proximity Read ↗

Genetic Variability in Molecular Pathways Implicated in Alzheimer's Disease: A Comprehensive ReviewSemantic proximity Read ↗

Opportunities in pharmacogenomics for the treatment of Alzheimer’s diseaseSemantic proximity Read ↗

Pharmacogenetic Considerations in the Treatment of Alzheimer’s DiseaseSemantic proximity Read ↗

Genomics and Functional Genomics of Alzheimer's Disease.Semantic proximity Read ↗

Pharmacogenomics for the treatment of dementia.Semantic proximity Read ↗

Genetics of Alzheimer's disease. A rapidly evolving field.Semantic proximity Read ↗

Genomics and phenotypic profiles in dementia: implications for pharmacological treatment.Semantic proximity Read ↗

Pharmacogenomics and treatment for dementia induced by Alzheimer's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.